Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Mk.33 Regulatory News (83NF)

Share Price Information for Natwest Mk.33 (83NF)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
83NF Live PriceLast checked at - London Stock Exchange

Intraday Natwest Mk.33 Share Chart

Registration Document and Base Prospectus

31 Mar 2021 16:10

RNS Number : 1824U
Natwest Markets PLC
31 March 2021
 

Publication of NatWest Markets Plc Registration Document and Base Prospectus

The following Registration Document and Base Prospectus have each been approved by the Financial Conduct Authority and are available for viewing:

NatWest Markets Plc Registration Document

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/1824U_2-2021-3-31.pdf

Base Prospectus relating to the NatWest Markets Plc US$10,000,000,000 US Medium-Term Note Programme dated 31 March 2021.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/1824U_1-2021-3-31.pdf

Copies of the above Registration Document and Base Prospectus have been submitted to the National Storage Mechanism and will shortly be available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

For further information, please contact:

Mark Anwender

Head of Documentation and Funding,

NatWest Treasury Markets

Tel: +44 20 7085 5143

 

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Base Prospectus and the Registration Document may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

 

Legal Entity Identifier: RR3QWICWWIPCS8A4S074

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIUARVRAVUOOAR
Date   Source Headline
20th Jan 20255:40 pmRNSPublication of Final Terms
8th Jan 20254:30 pmRNSPublication of Final Terms
6th Dec 20243:24 pmRNSPublication of Prospectus
14th Nov 20243:04 pmRNSPublication of Final Terms
12th Nov 20247:00 amRNSQ3 2024 Pillar 3
1st Nov 202410:06 amRNSPublication of Final Terms
25th Oct 20244:15 pmRNSPublication of Supplementary Prospectus
25th Oct 20247:00 amRNSNWM Plc Q3 Results 2024
23rd Sep 20245:42 pmRNSPublication of Final Terms
12th Sep 20244:43 pmRNSPublication of Supplementary Prospectus
11th Sep 20245:07 pmRNSDirectorate Change
23rd Aug 20245:13 pmRNSPublication of Pricing Supplement
22nd Aug 202410:28 amRNSPublication of Final Terms
21st Aug 202411:22 amRNSNOTICE TO NOTEHOLDERS
13th Aug 20247:18 amRNSH1 2024 Pillar 3
13th Aug 20247:00 amRNSQ1 2024 Pillar 3
9th Aug 20244:36 pmRNSPublication of Final Terms
7th Aug 202410:53 amRNSPublication of Final Terms
26th Jul 20243:27 pmRNSPublication of Supplementary Prospectus
26th Jul 20247:01 amRNSNWM Plc Interim Results 2024
18th Jul 20245:29 pmRNSNotice to Holders GEM Downsize
30th May 202411:37 amRNSNatWest Markets Substitution of Issuer
28th May 202410:04 amRNSPublication of Final Terms
28th May 202410:01 amRNSPublication of Final Terms
22nd May 202411:51 amRNSNotice of Change of Listing
16th May 20245:17 pmRNSPublication of Final Terms
16th May 20244:52 pmRNSPublication of Final Terms
14th May 20247:00 amRNSQ1 2024 Pillar 3
26th Apr 20245:25 pmRNSPublication of Supplementary Prospectus
26th Apr 20247:00 amRNSNWM Plc Q1 2024 Interim Management Statement
18th Mar 20245:12 pmRNSPublication of Supplementary Prospectus
18th Mar 20243:17 pmRNSNWM Plc Registration Document and Base Prospectus
16th Feb 202412:47 pmRNSPublication of Supplementary Prospectus
16th Feb 20247:01 amRNSAnnual Financial Report - NWM Plc
16th Feb 20247:01 amRNSFinal Results - NWM Plc
5th Jan 20245:44 pmRNSPublication of Final Terms
8th Dec 20239:54 amRNSPublication of a Prospectus
16th Nov 20234:51 pmRNSNotice of change in ECB Supervisory Classification
16th Nov 202310:09 amRNSNotice of change in ECB Supervisory Classification
3rd Nov 202312:57 pmRNSNotice of Results of Meeting
27th Oct 20231:14 pmRNSPublication of Supplementary Prospectus
27th Oct 20237:00 amRNSNWM Plc Q3 2023 Interim Management Statement
11th Oct 20233:45 pmRNSNotice of Meeting and Extraordinary Resolution
26th Sep 20231:25 pmRNSPublication of Final Terms
14th Sep 20233:48 pmRNSPublication of Final Terms
14th Aug 20237:00 amRNSH1 2023 Pillar 3
28th Jul 202311:44 amRNSNWM Publication of Supplementary Prospectus
28th Jul 20237:00 amRNSNWM Plc H1 2023 Interim Management Statement
21st Jun 202312:58 pmRNSPublication of Final Terms
19th Jun 20235:29 pmRNSReplacement RNS: Publication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.